dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
Published 4 years ago • 290 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:14
dr. lenz on updated results of the checkmate-142 trial in mcrc
-
5:59
nivolumab plus low-dose ipilimumab promising for treatment-naïve msi-high mcrc | heinz-josef lenz
-
0:53
dr. lenz on the safety profile of checkmate-142 trial in crc
-
2:03
promising checkmate-142 data for second-line ipilimumab plus nivolumab in mcrc
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
1:34
checkmate-142: updated data from msi high metastatic colon cancer patients
-
2:32
dr. overman discusses updated findings of checkmate-142 in patients with msi-h mcrc
-
2:51
implications of recent data from checkmate-142 in crc
-
2:37
moving forward with results from checkmate-142 in msi-h mcrc
-
1:00
dr. lenz on next steps with immunotherapy in mcrc
-
2:00
checkmate 8hw: first-line nivolumab plus ipilimumab in msi-h/dmmr mcrc
-
1:27
dr. lenz on later-line combo approaches in crc
-
2:04
dr. lenz on the changing landscape of metastatic colorectal cancer
-
3:44
keynote-177 & checkmate 142: checkpoint blockade in msi-h/dmmr crc
-
4:18
john leighton, md, comments on the outcomes of checkmate 142 in mcrc
-
1:19
dr. lenz on need for new treatment strategies in colorectal cancer
-
1:43
nivolumab, ipilimumab and panitumumab in mcrc
-
4:31
checkmate142: checkpoint combination therapy in first-line colorectal cancer